Yes, Rotavirus and Prevnar Can Be Given on the Same Day
Rotavirus vaccine may be administered concurrently with pneumococcal conjugate vaccine (Prevnar) on the same day. This is explicitly supported by American Academy of Pediatrics guidelines and FDA-approved labeling for both vaccines.
Guideline-Based Recommendation
The AAP clearly states that rotavirus vaccine may be administered concurrently with pneumococcal conjugate vaccine at the same visit 1. This recommendation applies to both rotavirus vaccine formulations:
FDA-Approved Concomitant Administration
The FDA label for Prevnar 20 specifically documents that pneumococcal conjugate vaccines were administered concomitantly with rotavirus vaccines in clinical trials 2. In these studies:
- 65.8% to 87.3% of participants received rotavirus vaccine with each of the first 3 doses of Prevnar 20 2
- Similar proportions received rotavirus vaccines across both study groups with no safety concerns identified 2
The RotaTeq FDA label confirms that it was evaluated concomitantly with pneumococcal conjugate vaccine, with no evidence of reduced antibody responses to vaccines administered together 3.
Clinical Trial Evidence Supporting Co-Administration
Multiple high-quality studies demonstrate the safety and immunogenicity of simultaneous administration:
A 2023 phase III trial in Thailand showed that rotavirus vaccine co-administered with PCV13 maintained robust immune responses, with similar anti-PCV13 antibody levels (range: 8.46-32.6 vs 7.53-33.1) and no safety concerns 4
A 2019 multicenter study confirmed that co-administration of rotavirus vaccine with PCV13 did not interfere with immune responses to either vaccine and had a clinically acceptable safety profile 5
A 2010 European study demonstrated that rotavirus vaccine co-administered with Prevnar was immunogenic and well tolerated, with immune responses to pneumococcal vaccines unaffected 6
A 2007 U.S. study showed antibody responses were similar when rotavirus vaccine was given concomitantly with pneumococcal conjugate vaccine, with rotavirus vaccine efficacy of 89.5% maintained 7
Practical Implementation
Administer both vaccines at the same visit when the infant is age-eligible:
- First doses typically given at 2 months of age 1
- Subsequent doses at 4 months (and 6 months for RotaTeq) 1
- Rotavirus vaccine is given orally; Prevnar is given intramuscularly at a separate injection site 2
Important Timing Considerations
For rotavirus vaccine specifically:
- First dose must be given between 6 weeks through 14 weeks, 6 days of age 1
- Minimum 4-week interval between rotavirus doses 1
- All doses must be completed by 8 months, 0 days of age 1
Common pitfall to avoid: Do not delay rotavirus vaccination waiting for a separate visit, as this may result in the infant aging out of eligibility for the first dose (>14 weeks, 6 days) 1.